Literature DB >> 7579388

Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells.

F W Jacobsen1, T Stokke, S E Jacobsen.   

Abstract

In contrast with the extensively characterized effects of transforming growth factor-beta (TGF-beta) on proliferation and differentiation of hematopoietic progenitors, little is known about the effects of TGF-beta on viability of normal hematopoietic progenitors. In the present report, we demonstrate that TGF-beta potently counteracts hematopoietic growth factor (HGF)-induced survival of individually cultured primitive Lin-Sca-1+ bone marrow progenitors. Specifically, 74% of single Lin-Sca-1+ cells cultured for 40 hours in the presence of stem cell factor (SCF) survived, whereas only 16% survived in the presence of SCF plus TGF-beta. Similarly, the enhanced survival of primitive hematopoietic progenitors in response to granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-1, IL-6, or IL-11 was also potently opposed by TGF-beta. Furthermore, it is demonstrated that neutralization of endogenous TGF-beta present in the cultures enhances survival of Lin-Sca-1+ progenitors in the absence, as well as in the presence, of HGFs such as SCF and IL-6. The reduced HGF-induced survival of primitive hematopoietic progenitors in the presence of TGF-beta was associated with increased apoptosis, as detected by an in situ terminal deoxynucleotidyl transferase (TdT) assay. After 16 hours of incubation in the absence of HGFs, 61% +/- 6% of the hematopoietic progenitors had DNA strand breaks characteristic of apoptosis. The presence of SCF reduced the frequency of apoptic cells to 27% +/- 5%, whereas 55% +/- 3% of the cells had signs of apoptosis in the presence of SCF plus TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579388

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 2.  TGF-β signaling and its role in the regulation of hematopoietic stem cells.

Authors:  Anuradha Vaidya; Vaijayanti P Kale
Journal:  Syst Synth Biol       Date:  2015-01-29

3.  Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

Authors:  Ilaria Ceglia; Amylou C Dueck; Francesca Masiello; Fabrizio Martelli; Wu He; Giulia Federici; Emanuel F Petricoin; Ann Zeuner; Camelia Iancu-Rubin; Rona Weinberg; Ronald Hoffman; John Mascarenhas; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2016-08-31       Impact factor: 3.084

4.  Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.

Authors:  M Takatoku; S Sellers; B A Agricola; M E Metzger; I Kato; R E Donahue; C E Dunbar
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.

Authors:  Genta Ishikawa; Naoto Fujiwara; Hadassa Hirschfield; Lilian Varricchio; Yujin Hoshida; Giovanni Barosi; Vittorio Rosti; Maria Padilla; Maria Mazzarini; Scott L Friedman; Ronald Hoffman; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2019-11-01       Impact factor: 3.084

6.  Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal.

Authors:  Deqiang Sun; Min Luo; Mira Jeong; Benjamin Rodriguez; Zheng Xia; Rebecca Hannah; Hui Wang; Thuc Le; Kym F Faull; Rui Chen; Hongcang Gu; Christoph Bock; Alexander Meissner; Berthold Göttgens; Gretchen J Darlington; Wei Li; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2014-05-01       Impact factor: 24.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.